I am a
Home I AM A Search Login

Papers of the Week

Papers: 20 Aug 2022 - 26 Aug 2022

Pharmacology/Drug Development

2022 Aug 12

Adv Ther

Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis.


We sought to identify and characterize distinct responder profiles among osteoarthritis (OA) subjects treated with tanezumab, nonsteroidal anti-inflammatory drugs (NSAIDs), or placebo.